Glutamate Pyruvate Transaminase (GPT) – Liver Enzyme
Glutamate pyruvate transaminase (GPT) is a liver enzyme measured in blood tests to assess liver function and detect liver cell damage.
Things worth knowing about "Glutamate Pyruvate Transaminase"
Glutamate pyruvate transaminase (GPT) is a liver enzyme measured in blood tests to assess liver function and detect liver cell damage.
What is Glutamate Pyruvate Transaminase?
Glutamate pyruvate transaminase (GPT), also known as alanine aminotransferase (ALT) or SGPT (serum glutamate pyruvate transaminase), is an enzyme found primarily in liver cells (hepatocytes). Smaller amounts are present in the kidneys, heart muscle, skeletal muscle, and pancreas. Under normal conditions, GPT is detectable in the blood only at very low concentrations.
Measuring the GPT level in the blood is a key component of liver function testing and is one of the most commonly ordered laboratory tests in clinical medicine.
Function and Mechanism of Action
GPT catalyzes a biochemical reaction in amino acid metabolism: it transfers an amino group from alanine to alpha-ketoglutarate, producing pyruvate and glutamate. This reaction plays an important role in both energy metabolism and the urea cycle within the liver.
Because this enzyme is predominantly located inside liver cells, its blood level rises significantly when liver cells are damaged and release their contents into the bloodstream. GPT is therefore considered a liver-specific marker of cell injury.
Clinical Significance and Diagnosis
GPT is measured as part of a blood test (liver panel). Reference ranges may vary slightly between laboratories, but typical values are:
- Women: up to approximately 35 U/L (units per liter)
- Men: up to approximately 45 U/L
Elevated GPT levels indicate damage or inflammation of liver cells. The degree of elevation and the clinical context help determine the underlying cause and severity.
Causes of Elevated GPT Levels
- Viral hepatitis (e.g., hepatitis A, B, C): marked elevation, often more than ten times the upper limit of normal
- Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): mild to moderate elevation
- Alcoholic liver disease: moderate elevation, often combined with elevated AST (GOT)
- Liver cirrhosis: variable levels depending on disease activity
- Drug-induced liver injury: e.g., from paracetamol, statins, or antibiotics
- Liver tumors or metastases
- Congestive heart failure with hepatic congestion
- Intense physical exercise or muscle disorders (less common, as GPT is also present in muscle tissue)
AST/ALT Ratio (De Ritis Ratio)
In clinical practice, GPT (ALT) is frequently evaluated together with GOT (glutamate oxaloacetate transaminase, AST). The AST/ALT ratio, known as the De Ritis ratio, provides important diagnostic clues:
- A ratio below 1 (ALT higher than AST) is more suggestive of viral hepatitis or fatty liver disease.
- A ratio above 2 (AST markedly higher than ALT) is more indicative of alcoholic liver disease.
When Should GPT Be Measured?
Testing for GPT levels is appropriate in the following situations:
- Suspected liver disease (e.g., jaundice, upper abdominal pain, unexplained fatigue)
- Follow-up monitoring in patients with known liver conditions
- Monitoring patients on medications with known hepatotoxic potential
- Screening in high-risk groups (e.g., obesity, excessive alcohol consumption, type 2 diabetes)
- Routine health check-ups
Management of Elevated GPT Levels
Treatment always targets the underlying cause. Elevated GPT is not a diagnosis in itself but a signal of possible liver injury. Depending on the cause, management may include:
- Alcohol abstinence in alcohol-related liver disease
- Weight loss and dietary changes in fatty liver disease
- Antiviral therapy for viral hepatitis
- Discontinuation or adjustment of hepatotoxic medications
- Regular monitoring of liver enzyme levels over time
References
- Longo DL et al. - Harrison's Principles of Internal Medicine, 20th edition (2018), McGraw-Hill Education.
- European Association for the Study of the Liver (EASL) - EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis (2021). Journal of Hepatology, 75(3), 659-689.
- Schiff ER, Maddrey WC, Reddy KR - Schiff's Diseases of the Liver, 12th edition (2018), Wiley-Blackwell.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryMacronutrients
Portion control
Food craving
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Glutamate Pyruvate Transaminase-en